Download PDF
Thromb Haemost 2008; 100(04): 716-718
DOI: 10.1160/TH08-04-0263
Letters to the Editor
Schattauer GmbH

Is VWF R924Q a benign polymorphism, a marker of a null allele or a factor VIII-binding defect? The debate continues with results from the UKHCDO VWD study

William Lester
1   Department of Haematology, University Hospital Birmingham, Birmingham, UK
,
Andrea Guilliatt
2   Department of Haematology, Birmingham Childrens Hospital, Birmingham, UK
,
Pamela Grundy
3   Molecular Diagnostics Centre, Manchester Royal Infirmary, Manchester, UK
,
Said Enayat
2   Department of Haematology, Birmingham Childrens Hospital, Birmingham, UK
,
Carolyn Millar
4   Department of Haematology, Royal Free & University College Medical School, London, UK
,
Frank Hill
2   Department of Haematology, Birmingham Childrens Hospital, Birmingham, UK
,
Tony Cumming
3   Molecular Diagnostics Centre, Manchester Royal Infirmary, Manchester, UK
,
Peter Collins
5   Department of Haematology, University of Wales College of Medicine, Cardiff, UK
› Author Affiliations
Further Information

Publication History

Received 27 April 2008

Accepted after minor revision 04 August 2008

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Hilbert L, Jorieux S, Proulle V. et al. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol 2003; 120: 627-632.
    CrossrefPubMedGoogle Scholar
  • 2 Casais P, Carballo GA, Woods AI. et al. R924Q substitution encoded within exon 21 of the von Willebrand factor gene related to mild bleeding phenotype. Thromb. Haemost 2006; 96: 228-230.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 James PD, Notley C, Hegadorn C. et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007; 109: 145-154.
    CrossrefPubMedGoogle Scholar
  • 4 Goodeve A, Eikenboom J, Castaman G. et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-121.
    CrossrefPubMedGoogle Scholar
  • 5 Cumming A, Grundy P, Keeney S. et al. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006; 96: 630-641.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Ganguly A, Rock M J, Prockop D J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325-10329.
    CrossrefPubMedGoogle Scholar
  • 7 O’Brien L A, James P D, Othman M. et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102: 549-557.
    CrossrefPubMedGoogle Scholar
  • 8 Mannucci P M, Lattuada A, Castaman G. et al. Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease. Blood 1989; 74: 2433-2436.
    PubMedGoogle Scholar
  • 9 Peerlinck K, Eikenboom J C, Ploos van Amstel HK. et al. A patient with von Willebrand’s disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J. Haematol 1992; 80: 358-363.
    CrossrefPubMedGoogle Scholar